Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|August 27, 2014
The wobbly status of ketolides: where do we stand?Nafsika H GeorgopapadakouDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 27, 2002
Infectious disease 2001: drug resistance, new drugsNafsika H GeorgopapadakouExpert Opinion on Investigational Drugs|October 6, 2004
Beta-lactamase inhibitors: evolving compounds for evolving resistance targetsNafsika H GeorgopapadakouExpert Opinion on Investigational Drugs|August 2, 2002
Antifungals targeted to protein modification: focus on protein N-myristoyltransferaseNafsika H GeorgopapadakouExpert Opinion on Investigational Drugs|November 12, 2013
Prospects for new antibacterials: can we do better?Nafsika H GeorgopapadakouDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Infectious disease 2000: drug resistance and new drugsNafsika H. GeorgopapadakouDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 26, 2004
New cancer therapeutics: target-specific in, cytotoxics out?Henk J Broxterman, Nafsika H GeorgopapadakouDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 15, 2007
Anticancer therapeutics: a surge of new developments increasingly target tumor and stromaHenk J Broxterman, Nafsika H GeorgopapadakouDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 13, 2005
Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinationsHenk J Broxterman, Nafsika H GeorgopapadakouAntimicrobial Agents and Chemotherapy|January 27, 2004
Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamasesGeoffrey W Stone, Qin Zhang, Rosario Castillo, et al.Pageof 1